PROCTER & GAMBLE Co 8-K, filed Jan 23, 2020
PROCTER & GAMBLE Co (PG)
8-K
2020-01-23
For: 2020-01-23
View Original
Added on
April 09, 2026
About this 8-K
PROCTER & GAMBLE Co filed this 8-K on January 23, 2020.
Items reported
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 23, 2020
PROCTERPROCTER & GAMBLE Coo
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
|
|
|
|
|||
|
(State or Other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|||
(Address of Principal Executive Offices, and Zip Code)
Registrant’s Telephone Number, Including Area Code
(Former Name or
Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| |
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act
of 1934 (§240.12b-2 of this chapter).
|
||
|
|
|
Emerging growth company
|
|
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | ||
ITEM 7.01 REGULATION FD DISCLOSURE
On January 23, 2020, The Procter & Gamble Company (the "Company") issued a press release
announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website.
This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure."
|
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
|
(d) Exhibits
|
Exhibit Number
|
|
Description
|
|
99.1
|
|
Informational Slides Provided by The Procter & Gamble Company dated January 23, 2020.
|
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
THE PROCTER & GAMBLE COMPANY
BY: /s/ Sandra T. Lane
Sandra T. Lane
Assistant Secretary
January 23, 2020
Earnings Release Q2 FY 2020January 23, 2020
Business ResultsQ2 FY 2020
Q2 FY 2020 HIGHLIGHTS
Q2 Fiscal Year 2020 Organic Sales Growth Organic Volume Growth Core EPS Growth Free Cash Flow
Productivity Q2 FY ‘20 +5% +3% +14% 100% Currency Neutral Core EPS Growth +15%
Q2 FY 2020 RESULTSORGANIC SALES GROWTH Organic sales were driven by volume, pricing and mix. Organic
volume up +3%, pricing +1% and mix +1%.
Q2 FY 2020 RESULTSCORE EPS GROWTH Core gross margin +200 basis pointsCore operating margin +190 basis
pointsTotal productivity savings +220 basis points
Q2 FY 2020 RESULTSCURRENCY-NEUTRAL CORE EPS GROWTH Core gross margin ex-FX +210 basis pointsCore
operating margin ex-FX +190 basis points
Business Segment Results and HighlightsQ2 FY 2020
+2% Pricing, +1% MixGlobal value share declined 0.2 versus year agoNet Earnings: Volume growth, pricing
and positive mix were partially offset by brand communication investments, production line start-up costs and currency headwinds. Q2 FY 2020 RESULTSBEAUTY SEGMENT
Hair Care organic sales grew mid-single digits versus year ago. Europe, Latin America and Greater China
grew high single digits and North America grew low single digits. Growth driven by innovation led volume growth, premium mix and strong retail execution. Skin & Personal Care organic sales grew double digits versus year ago with broad based
growth across all segments. Greater China grew double digits across Olay Skin, SK-II and Personal Care driven by superiority across vectors and pricing. North America Skin grew mid-teens behind premium innovation and Personal Care mid-single
digits driven by premium product innovation and pricing on Deodorants. Q2 FY 2020 RESULTSBEAUTY HIGHLIGHTS
+2% Pricing, flat Mix Global value share increased 0.3 points versus year ago. Net Earnings: Volume
growth, pricing and productivity savings were partially offset by currency headwinds and negative geographic mix. Q2 FY 2020 RESULTSGROOMING SEGMENT
Grooming organic sales increased mid-single digits versus year ago. Shave Care organic sales grew low
single digits. NA Shave grew organic sales low single digits behind premium innovation and go-to-market execution partially offset by the continued decline in shaving incidents and competitive activity. Europe Shave Care grew organic sales low
single digits behind premium innovation. Greater China Shave Care grew organic sales double digits driven by innovation, go-to-market execution and favorable product mix. Latin America grew mid-single digits driven by innovation and
devaluation-driven pricing. Appliances sales increased high single digits driven by a strong holiday execution and premium innovation mix. Q2 FY 2020 RESULTSGROOMING HIGHLIGHTS
+1% Pricing, +1% MixGlobal value share increased 0.3 points versus year agoNet Earnings: Innovation
driven volume growth, pricing and productivity savings were partially offset by currency headwinds and brand communication investments. Q2 FY 2020 RESULTSHEALTH CARE SEGMENT
Oral Care organic sales increased mid-single digits versus year ago. North America and Greater China both
grew high single digits driven by Power toothbrushes, premium toothpaste innovation and pricing. Europe grew mid-single digits with strong growth on Power toothbrushes. Latin America grew double digits driven by innovation-driven volume and
pricing. Personal Health Care organic sales increased high single digits versus year ago led by innovation-driven volume, pricing and positive mix behind strong growth in the respiratory segment. Q2 FY 2020 RESULTSHEALTH CARE HIGHLIGHTS
+1% Pricing, +1% MixGlobal value share increased 0.8 points versus year agoNet Earnings:
Innovation-driven volume growth, pricing, productivity savings and commodity tailwinds were partially offset by investments in brand communication. Q2 FY 2020 RESULTSFABRIC & HOME SEGMENT
Fabric Care organic sales grew mid-single digits versus year ago. Broad based growth led by premium
innovation-driven volume growth across laundry and fabric enhancers. Greater China delivered double digit organic sales growth and North America and Europe delivered mid-single digit organic sales growth. Asia Pacific region was down versus
year ago due to retailer inventory decreases post the October VAT increase.Home Care organic sales increased high single digits versus year ago with growth across all segments: Dish, Air and Surface. Sales increased from innovation-driven
volume, superior retail execution and pricing. Q2 FY 2020 RESULTSFABRIC & HOME HIGHLIGHTS
Flat Pricing, +1% MixGlobal value share declined 0.5 points versus year agoNet Earnings: Productivity
savings and commodity tailwinds were partially offset by brand communication investments, lower margin product mix hurt and currency headwinds. Q2 FY 2020 RESULTSBABY, FEMININE and FAMILY CARE SEGMENT
Baby Care organic sales decreased low single digits with strength of premium tier offerings and Pants
form more than offset by continued softness on mid-tier and value tier diapers due to competitive activity and category contraction in some markets. Asia Pacific region was also impacted by retailer inventory decreases in Japan post the October
VAT increase. Feminine Care organic sales increased mid-single digits versus year ago led by growth on premium innovation and favorable product mix from Always Discreet growth.Family Care organic sales increased low single digits versus year
ago led by innovation-driven volume and commodity based pricing partially offset by negative product/size mix. Q2 FY 2020 RESULTSBABY, FEMININE and FAMILY CARE HIGHLIGHTS
FY 2020 Guidance
FY ‘20 Organic Sales Growth (increased) +4% to +5% All-in Sales Growth (increased) +4% to +5%
Increased organic sales growth guidance to +4% to +5%Increased all-in sales growth to +4% to +5%Includes a modest negative impact from foreign exchange, which is largely offset by a positive net impact from acquisitions and divestitures. FY
2020 GuidanceSALES
FY ‘20 Core EPS Growth (increased) +8% to +11% All-in EPS Growth (increased) +235% to
+245% Increased Core EPS growth to +8% to +11% Core effective tax rate range of 17% to 18% Increased all-in EPS of +235% to +245% with the Gillette Shave Care carrying value adjustment in the base period (Q4). Impact in base is $3.03 on FY and
$3.02 in Q4. FY 2020 GuidanceEARNINGS PER SHARE
Increased Adj. Free Cash Flow Productivity: 100% Capital Spending, % Sales: 4.5% to 5.0%Dividends: Over
$7.5BIncreased Direct Share Repurchase: $7 to $8B FY 2020 GuidanceCASH GENERATION AND USAGE
Significant deceleration of market growth ratesSignificant currency weaknessSignificant commodity cost
increasesAdditional geo-political disruptions and economic volatility FY 2020 GuidancePOTENTIAL HEADWINDS NOT INCLUDED IN GUIDANCE
Forward Looking Statements Certain statements in this release or presentation, other than purely
historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within
the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words
“believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking
statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation
to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.Risks and uncertainties to which our forward-looking statements are subject
include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local,
regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to affect the expected share repurchases and dividend payments; (3) the ability to manage
disruptions in credit markets or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements)
and to manage disruption of business due to factors outside of our control, such as natural disasters and acts of war or terrorism; (5) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw
materials, and costs of labor, transportation, energy, pension and healthcare; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits
and technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such
as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues,
including concerns about safety, quality, ingredients, efficacy or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such
as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third party information technology systems, networks and services, and maintain the
security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage uncertainties related to changing political conditions (including the United Kingdom’s decision to leave
the European Union) and potential implications such as exchange rate fluctuations and market contraction; (13) the ability to successfully manage regulatory and legal requirements and matters (including, without limitation, those laws and
regulations involving product liability, product and packaging composition, intellectual property, antitrust, data protection, tax, environmental, and accounting and financial reporting) and to resolve pending matters within current estimates;
(14) the ability to manage changes in applicable tax laws and regulations including maintaining our intended tax treatment of divestiture transactions; (15) the ability to successfully manage our ongoing acquisition, divestiture and joint
venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; and (16) the ability to successfully achieve productivity improvements and
cost savings and manage ongoing organizational changes, while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited. For
additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.
The Procter & Gamble Company Regulation G Reconciliation of Non-GAAP Measures
The following provides definitions of the non-GAAP measures used in Procter & Gamble's January 23, 2020 earnings call, associated slides, and other
materials and the reconciliation to the most closely related GAAP measure. We believe that these measures provide useful perspective on underlying business trends (i.e. trends excluding non-recurring or unusual items) and results and provide a
supplemental measure of year-on-year results. The non-GAAP measures described below are used by Management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors
as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of management. Certain of these measures are also used to evaluate senior management and are a factor in
determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measure, but rather as supplemental information to our business results. These non-GAAP measures may not be
the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted. The Company is not able to reconcile its forward-looking non-GAAP adjusted cash flow productivity and effective
tax rate measures because the Company cannot predict the timing and amounts of discrete items such as acquisition and divestitures, which could significantly impact GAAP results.
The measures provided are as follows:
|
1.
|
Organic sales growth — page 3
|
|
2.
|
Core EPS and currency-neutral Core EPS — page 4
|
|
3.
|
Core gross margin and currency-neutral Core gross margin – page 5
|
|
4.
|
Core operating profit margin and currency-neutral Core operating profit margin — page 5
|
|
5.
|
Free cash flow productivity — page 6
|
Organic sales growth*: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures, the impact from the July 1, 2018 adoption of new accounting standards for “Revenue from Contracts with Customers”, and
foreign exchange from year-over-year comparisons. Management believes this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis.
The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures
adjusted as applicable for the following items:
|
•
|
Incremental restructuring:
The Company has had and continues to have an ongoing level of restructuring activities. Such activities have resulted in ongoing annual restructuring related charges of approximately $250 - $500 million before tax. In 2012 the Company
began a $10 billion strategic productivity and cost savings initiative that included incremental restructuring activities. In 2017, the Company communicated details of an additional multi-year productivity and cost savings plan. This
results in incremental restructuring charges to accelerate productivity efforts and cost savings. The adjustment to Core earnings includes only the restructuring costs above what we believe are the normal recurring level of
restructuring costs.
|
|
•
|
Early debt extinguishment charges: In fiscal 2018, the Company recorded after-tax charges of $243 million, due to the early extinguishment of certain long-term debt. These charges represent the difference between the reacquisition price and the par value of the
debt extinguished.
|
|
•
|
Transitional Impact of U.S. Tax Act: In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the "U.S. Tax Act"). This resulted in a net charge of $602 million for the
fiscal year 2018. The adjustment to Core earnings only includes this transitional impact. It does not include the ongoing impacts of the lower U.S. statutory rate on the respective years’ earnings.
|
|
•
|
Gain on Dissolution of the PGT Healthcare Partnership: The Company finalized the dissolution of our PGT Healthcare partnership, a venture between the Company and Teva Pharmaceuticals Industries, Ltd (Teva) in the OTC consumer healthcare business, in the quarter
ended September 30, 2018. The transaction was accounted for as a sale of the Teva portion of the PGT business; the Company recognized an after-tax gain on the dissolution of $353 million.
|
|
•
|
Shave Care Impairment: In
the fourth quarter of fiscal 2019, the company recognized a one-time, non-cash, after-tax charge of $8.0 billion ($8.3 billion before tax) to adjust the carrying values of the Shave Care reporting unit. This was comprised of a before
and after-tax impairment charge of $6.8 billion related to goodwill and an after-tax impairment charge of $1.2 billion ($1.6 billion before tax) to reduce the carrying value of the Gillette indefinite-lived intangible assets.
|
|
•
|
Anti-dilutive Impacts: The
Shave Care impairment charges caused certain equity instruments that are normally dilutive (and hence normally assumed converted or exercised for the purposes of determining diluted net earnings per share) to be anti-dilutive.
Accordingly, for U.S. GAAP diluted earnings per share, these instruments were not assumed to be concerted or exercised. Specifically, in the fourth quarter and total fiscal 2019, the weighted average outstanding preferred shares were
not included in the diluted weighted average common shares outstanding. Additionally, in the fourth quarter of fiscal 2019, none of our outstanding share-based equity awards were included in the diluted weighted average common shares
outstanding. As a result of the non-GAAP Shave Care impairment adjustment, these instruments are dilutive for non-GAAP earnings per share.
|
We do not view the above items to be part of our sustainable results, and their exclusion from core earnings measures provides a more
comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at-risk compensation. Management views the following non-GAAP measures as useful supplemental measures of Company
performance and operating efficiency over time.
Core EPS and currency-neutral Core EPS*: Core earnings per share, or Core EPS, is a measure of the Company's diluted net earnings per share from continuing operations adjusted as indicated. Currency-neutral Core EPS is a measure of the Company's Core EPS
excluding the incremental current year impact of foreign exchange.
Core gross margin:
Core gross margin is a measure of the Company's gross margin adjusted for items as indicated.
Currency-neutral Core gross margin: Currency-neutral Core gross margin is a measure of the Company's Core gross margin excluding the incremental current year impact of foreign exchange.
Core operating profit margin*: Core operating profit margin is a measure of the Company's operating margin adjusted for items as indicated.
Currency-neutral Core operating profit margin*: Currency-neutral Core operating profit margin is a measure of the Company's Core operating profit margin excluding the incremental current year impact of foreign exchange.
Free cash flow:
Free cash flow is defined as operating cash flow less capital spending. Free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. Management views free cash flow as
an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investment.
Free cash flow productivity*: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. Management views free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash.
Free cash flow productivity is used by management in making operating decisions, allocating financial resources and for budget planning purposes. The Company's long-term target is to generate annual free cash flow productivity at or above 90
percent.
* Measure is used to evaluate senior management and is a factor in determining their at-risk compensation.
1. Organic sales growth:
|
Three Months Ended
December 31, 2019 |
Net Sales Growth
|
Foreign Exchange Impact
|
Acquisition &
Divestiture Impact/Other* |
Organic Sales Growth
|
|||
|
Beauty
|
7%
|
1%
|
-%
|
8%
|
|||
|
Grooming
|
2%
|
2%
|
-%
|
4%
|
|||
|
Health Care
|
14%
|
1%
|
(8)%
|
7%
|
|||
|
Fabric Care & Home Care
|
4%
|
1%
|
-%
|
5%
|
|||
|
Baby, Feminine & Family Care
|
1%
|
1%
|
(1)%
|
1%
|
|||
|
Total P&G
|
5%
|
1%
|
(1)%
|
5%
|
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile
net sales to organic sales.
|
Six Months Ended
December 31, 2019 |
Net Sales Growth
|
Foreign Exchange Impact
|
Acquisition &
Divestiture Impact/Other* |
Organic Sales Growth
|
|||
|
Total P&G
|
6%
|
1%
|
(1)%
|
6%
|
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile
net sales to organic sales.
Organic Sales
2-Year Stacked Growth
|
Total Company
|
Net Sales Growth
|
Foreign Exchange Impact
|
Acquisition/ Divestiture Impact*
|
Organic Sales Growth
|
Average
|
|||
|
October – December 2018
|
-%
|
4%
|
-%
|
4%
|
||||
|
October – December 2019
|
5%
|
1%
|
(1)%
|
5%
|
4.5%
|
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures for all periods, the impact from the July
1, 2018 adoption of new accounting standards for "Revenue from Contracts with Customers" and rounding impacts necessary to reconcile net sales to organic sales.
Organic Sales
Calendar Year 2019
|
Total Company
|
Net Sales Growth
|
Foreign Exchange Impact
|
Acquisition &
Divestiture Impact/Other* |
Organic Sales Growth
|
|||
|
Calendar Year 2019
|
4%
|
3%
|
(1)%
|
6%
|
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures for all periods, the impact from the July
1, 2018 adoption of new accounting standards for "Revenue from Contracts with Customers" and rounding impacts necessary to reconcile net sales to organic sales.
Organic Sales
Prior Quarters
|
Total Company
|
Net Sales Growth
|
Foreign Exchange Impact
|
Acquisition/ Divestiture Impact/Other*
|
Organic Sales Growth
|
|||
|
JAS 2018
|
-%
|
3%
|
1%
|
4%
|
|||
|
OND 2018
|
-%
|
4%
|
-%
|
4%
|
|||
|
JFM 2019
|
1%
|
5%
|
(1%)
|
5%
|
|||
|
AMJ 2019
|
4%
|
4%
|
(1)%
|
7%
|
|||
|
JAS 2019
|
7%
|
2%
|
(2)%
|
7%
|
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures for all periods, the impact from the July 1, 2018 adoption
of new accounting standards for "Revenue from Contracts with Customers" and rounding impacts necessary to reconcile net sales to organic sales.
Organic Sales
Guidance
|
Total Company
|
Net Sales Growth
|
Combined Foreign Exchange &
Acquisition/Divestiture Impact/Other*
|
Organic Sales Growth
|
|||
|
FY 2020 (Estimate)
|
4% to 5%
|
-%
|
+4% to +5%
|
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to
organic sales.
2. Core EPS and currency-neutral Core EPS:
|
Three Months Ended
December 31 |
|||
|
2019
|
2018
|
||
|
Diluted Net Earnings Per Share
|
$1.41
|
$1.22
|
|
|
Incremental Restructuring
|
0.01
|
0.03
|
|
|
Core EPS
|
$1.42
|
$1.25
|
|
|
Percentage change vs. prior period
|
14%
|
||
|
Currency Impact to Earnings
|
0.02
|
||
|
Currency-Neutral Core EPS
|
$1.44
|
||
|
Percentage change vs. prior period Core EPS
|
15%
|
||
Note – All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction.
|
Six Months Ended
December 31 |
|||
|
2019
|
2018
|
||
|
Diluted Net Earnings Per Share
|
$2.77
|
$2.44
|
|
|
Incremental Restructuring
|
0.02
|
0.06
|
|
|
Gain on Dissolution of PGT Partnership
|
(0.14)
|
||
|
Core EPS
|
$2.79
|
$2.36
|
|
|
Percentage change vs. prior period
|
18%
|
||
|
Currency Impact to Earnings
|
0.03
|
||
|
Currency-Neutral Core EPS
|
$2.82
|
||
|
Percentage change vs. prior period Core EPS
|
19%
|
||
Note – All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction.
Core EPS
Prior Quarters
|
JAS 18
|
JAS 17
|
OND 18
|
OND 17
|
JFM 19
|
JFM 18
|
AMJ 19
|
AMJ 18
|
JAS 19
|
JAS 18
|
|
|
Diluted Net Earnings Per Share from Continuing Operations, attributable to P&G
|
$ 1.22
|
$ 1.06
|
$ 1.22
|
$ 0.93
|
$ 1.04
|
$ 0.95
|
$ (2.12)
|
$ 0.72
|
$ 1.36
|
$ 1.22
|
|
Incremental Restructuring
|
0.03
|
0.03
|
0.03
|
0.02
|
0.02
|
0.04
|
0.06
|
0.14
|
0.01
|
0.03
|
|
Early Debt Extinguishment Charges
|
-
|
0.09
|
||||||||
|
Transitional Impact of U.S. Tax Act
|
0.24
|
0.01
|
(0.02)
|
|||||||
|
Gain on Dissolution of PGT Partnership
|
(0.14)
|
(0.14)
|
||||||||
|
Shave Care Impairment
|
3.02
|
|||||||||
|
Anti-dilutive Impacts
|
0.14
|
|||||||||
|
Rounding
|
0.01
|
0.01
|
0.01
|
|||||||
|
Core EPS
|
$ 1.12
|
$ 1.09
|
$ 1.25
|
$ 1.19
|
$ 1.06
|
$ 1.00
|
$ 1.10
|
$ 0.94
|
$ 1.37
|
$ 1.12
|
|
Percentage change vs. prior period
|
3%
|
5%
|
6%
|
17%
|
22%
|
|||||
|
Currency Impact to Earnings
|
0.09
|
0.09
|
0.09
|
0.08
|
0.02
|
|||||
|
Currency-Neutral Core EPS
|
$ 1.21
|
$ 1.34
|
$ 1.15
|
$ 1.18
|
$1.39
|
|||||
|
Percentage change vs. prior period Core EPS
|
11%
|
13%
|
15%
|
26%
|
24%
|
Core EPS
Guidance
|
Total Company
|
Diluted EPS Growth
|
Impact of Incremental
Non-Core Items*
|
Core EPS Growth
|
|
FY 2020 (Estimate)
|
+235% to +245%
|
(227)% to (234)%
|
+8% to +11%
|
* Includes the gain on the dissolution of the PGT Healthcare partnership and Shave Care impairment in fiscal 2019 and year-over-year changes in incremental non-core
restructuring charges.
3. Core gross margin:
|
Three Months Ended
December 31 |
||
|
2019
|
2018
|
|
|
Gross Margin
|
51.4%
|
48.9%
|
|
Incremental Restructuring
|
0.2%
|
0.7%
|
|
Core Gross Margin
|
51.6%
|
49.6%
|
|
Basis point change vs. prior year Core margin
|
200
|
|
|
Currency Impact to Margin
|
0.1%
|
|
|
Currency-Neutral Core Gross Margin
|
51.7%
|
|
|
Basis point change vs prior year Core margin
|
210
|
|
4. Core operating profit margin:
|
Three Months Ended
December 31 |
||
|
2019
|
2018
|
|
|
Operating Profit Margin
|
24.6%
|
22.3%
|
|
Incremental Restructuring
|
0.1%
|
0.5%
|
|
Core Operating Profit Margin
|
24.7%
|
22.8%
|
|
Basis point change vs. prior year Core margin
|
190
|
|
|
Currency Impact Margin
|
-%
|
|
|
Currency-Neutral Core Operating Profit Margin
|
24.7%
|
|
|
Basis point change vs. prior year Core Margin
|
190
|
|
5. Free cash flow productivity (dollar amounts in millions):
|
Three Months Ended December 31, 2019
|
||||
|
Operating Cash Flow
|
Capital Spending
|
Free Cash Flow
|
Net Earnings
|
Free Cash Flow
Productivity
|
|
$4,364
|
$(605) |
$3,759
|
$3,743
|
100%
|